Acidic tumor microenvironment abrogates the efficacy of mTORC1 inhibitors

被引:54
作者
Faes, Seraina [1 ,2 ]
Duval, Adrian P. [1 ,2 ,6 ]
Planche, Anne [1 ,2 ]
Uldry, Emilie [1 ,2 ]
Santoro, Tania [1 ,2 ]
Pythoud, Catherine [1 ,2 ]
Stehle, Jean-Christophe [3 ,4 ]
Horlbeck, Janine [3 ,4 ]
Letovanec, Igor [4 ,5 ]
Riggi, Nicolo [4 ,5 ]
Demartines, Nicolas [1 ,2 ]
Dormond, Olivier [1 ,2 ]
机构
[1] CHU Vaudois, Lausanne Univ Hosp, Pavillon 4,Av Beaumont, CH-1011 Lausanne, Switzerland
[2] Univ Lausanne, Pavillon 4,Av Beaumont, CH-1011 Lausanne, Switzerland
[3] CHU Vaudois, Univ Lausanne Hosp, Mouse Pathol Facil, Lausanne, Switzerland
[4] Univ Lausanne, Lausanne, Switzerland
[5] CHU Vaudois, Univ Lausanne Hosp, Inst Pathol, Lausanne, Switzerland
[6] Ecole Polytech Fed Lausanne, Swiss Fed Inst Lausanne, Swiss Inst Expt Canc Res ISREC, Lausanne, Switzerland
基金
瑞士国家科学基金会;
关键词
Tumor Microenvironment; Acidity; mTORC1; Rapamycin; Sodium Bicarbonate; Resistance Mechanisms; SODIUM-BICARBONATE; SYSTEMIC BUFFERS; CELL-GROWTH; PH; ACIDOSIS; PHOSPHORYLATION; CARCINOGENESIS; EVEROLIMUS; RESISTANCE; CARCINOMA;
D O I
10.1186/s12943-016-0562-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Blocking the mechanistic target of rapamycin complex-1 (mTORC1) with chemical inhibitors such as rapamycin has shown limited clinical efficacy in cancer. The tumor microenvironment is characterized by an acidic pH which interferes with cancer therapies. The consequences of acidity on the anti-cancer efficacy of mTORC1 inhibitors have not been characterized and are thus the focus of our study. Methods: Cancer cell lines were treated with rapamycin in acidic or physiological conditions and cell proliferation was investigated. The effect of acidity on mTORC1 activity was determined by Western blot. The anticancer efficacy of rapamycin in combination with sodium bicarbonate to increase the intratumoral pH was tested in two different mouse models and compared to rapamycin treatment alone. Histological analysis was performed on tumor samples to evaluate proliferation, apoptosis and necrosis. Results: Exposing cancer cells to acidic pH in vitro significantly reduced the anti-proliferative effect of rapamycin. At the molecular level, acidity significantly decreased mTORC1 activity, suggesting that cancer cell proliferation is independent of mTORC1 in acidic conditions. In contrast, the activation of mitogen-activated protein kinase (MAPK) or AKT were not affected by acidity, and blocking MAPK or AKT with a chemical inhibitor maintained an anti-proliferative effect at low pH. In tumor mouse models, the use of sodium bicarbonate increased mTORC1 activity in cancer cells and potentiated the anti-cancer efficacy of rapamycin. Combining sodium bicarbonate with rapamycin resulted in increased tumor necrosis, increased cancer cell apoptosis and decreased cancer cell proliferation as compared to single treatment. Conclusions: Taken together, these results emphasize the inefficacy of mTORC1 inhibitors in acidic conditions. They further highlight the potential of combining sodium bicarbonate with mTORC1 inhibitors to improve their anti-tumoral efficacy.
引用
收藏
页数:11
相关论文
共 40 条
[31]   Disrupting proton dynamics and energy metabolism for cancer therapy [J].
Parks, Scott K. ;
Chiche, Johanna ;
Pouyssegur, Jacques .
NATURE REVIEWS CANCER, 2013, 13 (09) :611-623
[32]   Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy [J].
Pilon-Thomas, Shari ;
Kodumudi, Krithika N. ;
El-Kenawi, Asmaa E. ;
Russell, Shonagh ;
Weber, Amy M. ;
Luddy, Kimberly ;
Damaghi, Mehdi ;
Wojtkowiak, Jonathan W. ;
Mule, James J. ;
Ibrahim-Hashim, Arig ;
Gillies, Robert J. .
CANCER RESEARCH, 2016, 76 (06) :1381-1390
[33]   Enhancement of chemotherapy by manipulation of tumour pH [J].
Raghunand, N ;
He, X ;
van Sluis, R ;
Mahoney, B ;
Baggett, B ;
Taylor, CW ;
Paine-Murrieta, G ;
Roe, D ;
Bhujwalla, ZM ;
Gillies, RJ .
BRITISH JOURNAL OF CANCER, 1999, 80 (07) :1005-1011
[34]  
ROBBINS PF, 1991, CANCER RES, V51, P3657
[35]   Bicarbonate Increases Tumor pH and Inhibits Spontaneous Metastases [J].
Robey, Ian F. ;
Baggett, Brenda K. ;
Kirkpatrick, Nathaniel D. ;
Roe, Denise J. ;
Dosescu, Julie ;
Sloane, Bonnie F. ;
Hashim, Arig Ibrahim ;
Morse, David L. ;
Raghunand, Natarajan ;
Gatenby, Robert A. ;
Gillies, Robert J. .
CANCER RESEARCH, 2009, 69 (06) :2260-2268
[36]   Development of PI3K inhibitors: lessons learned from early clinical trials [J].
Rodon, Jordi ;
Dienstmann, Rodrigo ;
Serra, Violeta ;
Tabemero, Josep .
NATURE REVIEWS CLINICAL ONCOLOGY, 2013, 10 (03) :143-153
[37]   Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex [J].
Sarbassov, DD ;
Guertin, DA ;
Ali, SM ;
Sabatini, DM .
SCIENCE, 2005, 307 (5712) :1098-1101
[38]   The Potential Role of Systemic Buffers in Reducing Intratumoral Extracellular pH and Acid-Mediated Invasion [J].
Silva, Ariosto S. ;
Yunes, Jose A. ;
Gillies, Robert J. ;
Gatenby, Robert A. .
CANCER RESEARCH, 2009, 69 (06) :2677-2684
[39]   Drug Resistance and Cellular Adaptation to Tumor Acidic pH Microenvironment [J].
Wojtkowiak, Jonathan W. ;
Verduzco, Daniel ;
Schramm, Karla J. ;
Gillies, Robert J. .
MOLECULAR PHARMACEUTICS, 2011, 8 (06) :2032-2038
[40]   Everolimus for Advanced Pancreatic Neuroendocrine Tumors. [J].
Yao, James C. ;
Shah, Manisha H. ;
Ito, Tetsuhide ;
Bohas, Catherine Lombard ;
Wolin, Edward M. ;
Van Cutsem, Eric ;
Hobday, Timothy J. ;
Okusaka, Takuji ;
Capdevila, Jaume ;
de Vries, Elisabeth G. E. ;
Tomassetti, Paola ;
Pavel, Marianne E. ;
Hoosen, Sakina ;
Haas, Tomas ;
Lincy, Jeremie ;
Lebwohl, David ;
Oberg, Kjell .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (06) :514-523